Treatments used for obsessive-compulsive disorder : an international perspective

• Autores: Brakoulias, Vlasios; Starcevic, Vladan; Albert, Umberto; Arumugham, Shyam Sundar; Bailey, Brenda E.; Belloch, Amparo; Borda, Tania; Dell'Osso, Liliana; Elias, Jason A.; Falkenstein, Martha J.; Ferrao, Ygor A.; Fontenelle, Leonardo F.; Jelinek, Lena; Kalogeraki, Leto; Kay, Brian; Laurito, Luana D.; Lochner, Christine; Maina, Giuseppe; Marazziti, Donatella; Martin, Andrew; Matsunaga, Hisato; Miguel, Eurípedes C.; Morgado, Pedro; Mourikis, Irakis; Pasquini, Massimo; Perez Rivera, Rodrigo; Potluri, Sriramya; Reddy, Janardhan Y. C.; Riemann, Brian C.; do Rosario, Maria Conceição; Shavitt, Roseli G.; Stein, Dan J.; Viswasam, Kirupumani; Wang, Zhen; Fineberg, Naomi A.
• Año de publicación: 2019
• Idioma: inglés
• Tipo de recurso: artículo
• Fuente: Human Psychopharmacology: Clinical & Experimental. 2019, 34(1)
• Materia: TERAPIA PSICOANALITICA; BENZODIAZEPINAS; ANTIPSICOTICOS; TRASTORNO OBSESIVO COMPULSIVO; FARMACOTERAPIA; SEROTONINA; PSICOFARMACOLOGIA; PSICOTROPICOS
• Institución: Pontificia Universidad Católica Argentina

Fil: Brakoulias, Vlasios. University of Sydney. Sydney Medical School. Nepean Hospital. Department of Psychiatry; Australia
Fil: Starcevic, Vladan. University of Sydney. Sydney Medical School. Nepean Hospital. Department of Psychiatry; Australia
Fil: Albert, Umberto. University of Turin. Rita Levi Montalcini Department of Neuroscience; Italia
Fil: Albert, Umberto. University of Bologna. Department of Biomedical and Neuromotor Sciences; Italia
Fil: Arumugham, Shyam Sundar. National Institute of Mental Health and Neurosciences. Department of Psychiatry; India
Fil: Bailey, Brenda E. Rogers Memorial Hospital. Department of Psychiatry; Estados Unidos
Fil: Belloch, Amparo. Universidad de Valencia. Faculty of Psychology. Research Unit for Obsessive‐Compulsive and Related Disorders. Department of Personality Psychology; España
Fil: Borda, Tania. Bio‐Behavioral Institute BA. Department of Psychiatry; Argentina
Fil: Borda, Tania. Pontificia Universidad Católica Argentina; Facultad de Psicología y Psicopedagogía. Departamento de Psicología; Argentina
Fil: Dell'Osso, Liliana. University of Pisa. Dipartmento di Farmacia. Section of Psychiatry; Italia
Fil: Dell'Osso, Liliana. University of Pisa. Dipartimento di Medicina Clinica e Sperimentale; Italia
Fil: Elias, Jason A. Harvard Medical School. McLean Hospital. Department of Psychiatry; Estados Unidos
Fil: Falkenstein, Martha J. Harvard Medical School. McLean Hospital. Department of Psychiatry; Estados Unidos
Fil: Ferrao, Ygor A. Federal University of Health Sciences of Porto Alegre. Department of Psychiatry; Brasil
Fil: Fontenelle, Leonardo F. Federal University of Rio de Janeiro. Department of Psychiatry and Legal Medicine; Brasil
Fil: Fontenelle, Leonardo F. D'Or Institute for Research and Education. Department of Psychiatry; Brasil
Fil: Fontenelle, Leonardo F. Monash University. Monash Institute of Cognitive and Clinical Neurosciences; Australia
Fil: Jelinek, Lena. Universitätsklinikum Hamburg‐Eppendorf. Department of Psychology; Alemania
Fil: Kalogeraki, Leto. National and Kapodistrian University of Athens. Division of Psychiatry I. Behavioral Therapy Department. Outpatient Clinic for OCD and Related Disorders; Grecia
Fil: Kay, Brian. Rogers Memorial Hospital. Department of Psychiatry; Estados Unidos
Fil: Laurito, Luana D. Federal University of Rio de Janeiro. Department of Psychiatry and Legal Medicine; Brasil
Fil: Laurito, Luana D. D'Or Institute for Research and Education. Department of Psychiatry; Brasil
Fil: Laurito, Luana D. Monash University. Monash Institute of Cognitive and Clinical Neurosciences; Australia
Fil: Lochner, Christine. University of Stellenbosch. Department of Psychiatry. MRC Unit on Anxiety Disorders; Sudáfrica
Fil: Maina, Giuseppe. University of Bologna. Department of Biomedical and Neuromotor Sciences; Italia
Fil: Marazziti, Donatella. University of Pisa. Dipartmento di Farmacia. Section of Psychiatry; Italia
Fil: Marazziti, Donatella. Dipartimento di Medicina Clinica e Sperimentale; Italia
Fil: Martin, Andrew. The University of Sydney. NHMRC Clinical Trials Centre; Australia
Fil: Matsunaga, Hisato. Hyogo College of Medicine. Department of Neuropsychiatry; Japón
Fil: Miguel, Eurípedes C. University of São Paulo. Department and Institute of Psychiatry; Brasil
Fil: Morgado, Pedro. University of Minho. School of Health Sciences. Life and Health Sciences Research Institute; Portugal
Fil: Morgado, Pedro. ICVS‐3Bs—PT Government Associate Laboratory. Department of Psychiatry; Portugal
Fil: Morgado, Pedro. Hospital de Braga. Department of Psychiatry; Portugal
Fil: Mourikis, Irakis. National and Kapodistrian University of Athens. Division of Psychiatry I. Behavioral Therapy Department. Outpatient Clinic for OCD and Related Disorders; Grecia
Fil: Pasquini, Massimo. Sapienza University of Rome. Department of Human Neurosciences; Italia
Fil: Perez Rivera, Rodrigo. Bio‐Behavioral Institute BA. Department of Psychiatry; Argentina
Fil: Potluri, Sriramya. Harvard Medical School. McLean Hospital. Department of Psychiatry; Estados Unidos
Fil: Reddy, Janardhan Y. C. National Institute of Mental Health and Neurosciences. Department of Psychiatry; India
Fil: Riemann, Brian C. Rogers Memorial Hospital. Department of Psychiatry; Estados Unidos
Fil: do Rosario, Maria Conceição. Federal University of São Paulo. Department of Psychiatry; Brasil
Fil: Shavitt, Roseli G. Federal University of Health Sciences of Porto Alegre. Department of Psychiatry; Brasil
Fil: Stein, Dan J. University of Stellenbosch. Department of Psychiatry. MRC Unit on Anxiety Disorders; SudáfricaUniversity of Stellenbosch. Department of Psychiatry. MRC Unit on Anxiety Disorders; Sudáfrica
Fil: Viswasam, Kirupumani. University of Sydney. Sydney Medical School. Nepean Hospital. Department of Psychiatry; Australia
Fil: Wang, Zhen. Shanghai Jiao Tong University. School of Medicine. Shanghai Mental Health Center; China
Fil: Wang, Zhen. Shanghai Key Laboratory of Psychotic Disorders Department of Psychiatry; China
Fil: Fineberg, Naomi A. University of Hertfordshire. Department of Psychiatry; Inglaterra
Abstract: Objective: The objective of this study was to characterise international trends in the use of psychotropic medication, psychological therapies, and novel therapies used to treat obsessive–compulsive disorder (OCD). Methods: Researchers in the field of OCD were invited to contribute summary statistics on the characteristics of their samples. Consistency of summary statistics across countries was evaluated. Results: The study surveyed 19 expert centres from 15 countries (Argentina, Australia, Brazil, China, Germany, Greece, India, Italy, Japan, Mexico, Portugal, South Africa, Spain, the United Kingdom, and the United States) providing a total sample of 7,340 participants. Fluoxetine (n = 972; 13.2%) and fluvoxamine (n = 913; 12.4%) were the most commonly used selective serotonin reuptake inhibitor medications. Risperidone (n = 428; 7.3%) and aripiprazole (n = 415; 7.1%) were the most commonly used antipsychotic agents. Neurostimulation techniques such as transcranial magnetic stimulation, deep brain stimulation, gamma knife surgery, and psychosurgery were used in less than 1% of the sample. There was significant variation in the use and accessibility of exposure and response prevention for OCD. Conclusions: The variation between countries in treatments used for OCD needs further evaluation. Exposure and response prevention is not used as frequently as guidelines suggest and appears difficult to access in most countries. Updated treatment guidelines are recommended.